title: Adverse dermatologic effects of cardiovascular drug therapy: part III.
abstract: Cardiovascular disease is common, affecting an increasing number of persons as the population ages. To combat this growing health problem, physicians use a multitude of medications in the treatment of their patients. Although pharmacologic therapy greatly enhances quality of life for a majority of patients, there is always the potential for an unfavorable reaction. For example, cardiovascular drugs can induce a vast array of adverse dermatologic responses. This article reviews the various cutaneous reaction patterns that can occur as a result of treatment with vasodilators and other antihypertensive drugs, anticoagulants and antiplatelet drugs, thrombolytic agents, and lipid-lowering agents.
authors.affiliation: Department of Medicine, New York Medical College, Valhalla, USA.
authors.forename: William H
authors.initials: WH
authors.lastname: Frishman
authors.forename: Brian D
authors.initials: BD
authors.lastname: Brosnan
authors.forename: Marc
authors.initials: M
authors.lastname: Grossman
authors.forename: Debasish
authors.initials: D
authors.lastname: Dasgupta
authors.forename: Diana K
authors.initials: DK
authors.lastname: Sun
mesh_terms: D002317:Cardiovascular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006801:Humans; D012871:Skin Diseases / Q000139:chemically induced*
chemical_list: D002317:Cardiovascular Agents